GURU.Markets stock price, segment price, and overall market index valuation
The company's share price STAAR Surgical Company
STAAR Surgical produces implantable contact lenses (ICLs), an alternative to laser vision correction. Its stock price has been a rapid growth story, driven by the uniqueness of its product and its growing popularity, particularly in Asia.
Share prices of companies in the market segment - Medical instruments
STAAR Surgical produces implantable contact lenses (ICLs), which is its sole segment. We classify it as part of the Medical Instruments sector, and the chart below reflects the dynamics of the entire refractive surgery industry, where its product competes with laser correction.
Broad Market Index - GURU.Markets
STAAR Surgical develops and manufactures implantable vision correction lenses that offer an alternative to laser surgery. Its innovative products make it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how STAAR compares to it.
Change in the price of a company, segment, and market as a whole per day
STAA - Daily change in the company's share price STAAR Surgical Company
Daily fluctuations in STAAR Surgical, a manufacturer of implantable lenses, reflect innovation in ophthalmology. Change_co reflects sensitivity to regulatory approvals and surgeon acceptance of the technology. This metric is key to analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medical instruments
STAAR Surgical Company is a manufacturer of implantable lenses. This chart highlights the high volatility of the MedTech sector. Comparing this to STAA, a growing player in the vision correction market, helps us understand how its business model is ahead of industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
STAAR Surgical is a manufacturer of implantable contact lenses, an alternative to laser vision correction. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how STAAR shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization STAAR Surgical Company
STAAR Surgical is a manufacturer of revolutionary implantable lenses, an alternative to LASIK. Its year-over-year performance reflects its rapid growth and the adoption of its technology in clinical practice. The chart below tells the story of this medical technology leader.
Annual dynamics of market capitalization of the market segment - Medical instruments
STAAR Surgical Company has revolutionized vision correction with its EVO ICL implantable lens, an alternative to LASIK. Its rapid growth is fueled by the acceptance of its technology by surgeons and patients. This chart shows how its innovative product and dominant market position allow it to significantly outpace the industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
STAAR Surgical, with its implantable lenses, is a growth story in medicine. Its stock price is driven not by economics, but by the speed of technology adoption by surgeons and patients. The chart illustrates how a breakthrough technology can gain market share in the conservative but vast ophthalmology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization STAAR Surgical Company
The growth of STAAR Surgical, a manufacturer of implantable lenses, depends on the adoption of its technology. Monthly fluctuations on the chart reflect the growth in the number of procedures for implanting its lenses, which are an alternative to laser vision correction, a key indicator of its operational growth.
Monthly dynamics of market capitalization of the market segment - Medical instruments
STAAR Surgical Company has revolutionized refractive surgery with its implantable collamer lenses (ICLs), an alternative to LASIK. The growth of the medical device sector, shown in the graph, reflects the introduction of new technologies. Against this backdrop, one can appreciate how STAAR's unique and patented product enables it to demonstrate high growth rates in the vision correction market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
STAAR Surgical produces and sells implantable lenses as an alternative to laser vision correction. It is a fast-growing company in the healthcare sector. A market trend chart shows how strong its own growth trend, driven by the introduction of its technology, allows STAAR shares to move independently of overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization STAAR Surgical Company
STAAR Surgical, a manufacturer of implantable vision correction lenses, whose weekly stock price reflects competition from laser surgery and growth in international markets. Regulatory approvals and data on increasing procedure volumes are shaping short-term expectations, demonstrating demand for innovation in ophthalmology.
Weekly dynamics of market capitalization of the market segment - Medical instruments
STAAR Surgical, a manufacturer of implantable lenses, is part of the medical technology sector. The graph compares its performance with the industry, demonstrating how its innovative product allows it to stay ahead of general trends in ophthalmology that impact all players.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
STAAR Surgical produces implantable lenses for vision correction. The company's growth is driven by medical needs and innovation. The chart shows how STAAR's stock price is unaffected by overall market fluctuations, riding the wave of adoption of its technology as an alternative to LASIK.
Market capitalization of the company, segment and market as a whole
STAA - Market capitalization of the company STAAR Surgical Company
The STAAR Surgical chart is a financial story of freedom from glasses and contact lenses. The market capitalization of this company, which produces implantable contact lenses (ICLs), reflects investors' faith in its technology as an alternative to LASIK. Its growth is a bet that more and more people will choose a reversible and less invasive vision correction option.
STAA - Share of the company's market capitalization STAAR Surgical Company within the market segment - Medical instruments
STAAR Surgical develops and manufactures implantable collamer lenses (ICLs) for vision correction, serving as an alternative to LASIK. Its market share in the medical device sector reflects its dominant position in this niche. The chart below shows how successful the company is in promoting its unique technology to ophthalmologists and patients.
Market capitalization of the market segment - Medical instruments
STAAR Surgical produces implantable lenses that offer an alternative to laser vision correction. The chart below shows the overall market capitalization of the entire medical equipment sector. Its growth reflects demand for new ophthalmological technologies and demographic trends.
Market capitalization of all companies included in a broad market index - GURU.Markets
STAAR Surgical is a company that challenged laser vision correction with its implantable lenses. Its market capitalization chart tells the story of a technological alternative, demonstrating how an innovative ophthalmological product can win back market share in an established medical market.
Book value capitalization of the company, segment and market as a whole
STAA - Book value capitalization of the company STAAR Surgical Company
For STAAR Surgical, a manufacturer of implantable lenses, book value is its high-tech manufacturing capabilities. The chart below shows how the company is investing in production expansion. Growth is directly linked to its ability to meet growing global demand for its innovative product.
STAA - Share of the company's book capitalization STAAR Surgical Company within the market segment - Medical instruments
STAAR Surgical produces implantable lenses as an alternative to LASIK. Manufacturing these high-tech medical devices requires ultra-clean and modern manufacturing facilities. The asset share chart shows how the company is investing in the physical infrastructure needed to create its unique products.
Market segment balance sheet capitalization - Medical instruments
STAAR Surgical produces implantable lenses for vision correction. This is a high-tech medical product that requires precise and sterile manufacturing. The book value chart shows the investments in specialized equipment and cleanrooms required to create innovative ophthalmological solutions.
Book value of all companies included in the broad market index - GURU.Markets
STAAR Surgical's assets are a high-tech manufacturing facility that restores vision. The company's book value reflects its factories in the US and Switzerland, where implantable lenses are created under sterile conditions. This is a capital-intensive resource necessary for the production of one of the most advanced ophthalmic products.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - STAAR Surgical Company
STAAR Surgical produces implantable lenses for vision correction—an alternative to LASIK. Its book value is minimal compared to the market. Investors value its unique technology, patents, and growth potential in the global ophthalmology market. The chart shows a significant premium for medical innovation.
Market to book capitalization ratio in a market segment - Medical instruments
STAAR Surgical produces implantable lenses for vision correction—an innovative product. The company's value lies in its patents and technology, not its manufacturing facilities. This chart shows how highly the market values its potential to displace traditional vision correction methods, which is reflected in the premium to its book value.
Market to book capitalization ratio for the market as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction. The company's value lies in its unique, patented technology and growing market penetration. The market values it as a medical technology company, not just a manufacturer. The chart shows the premium investors place on life-changing innovations.
Debts of the company, segment and market as a whole
STAA - Company debts STAAR Surgical Company
STAAR Surgical, a manufacturer of implantable lenses, uses debt to fund growth and marketing. This chart shows how the company invests in clinical trials to obtain approval in new countries and in expensive marketing campaigns to increase awareness of its products among surgeons and patients. Debt accelerates global expansion.
Market segment debts - Medical instruments
STAAR Surgical develops and manufactures implantable lenses for vision correction, serving as an alternative to LASIK. In the medical device sector, debt is often used for clinical trials, regulatory approvals, and marketing to physicians. The chart shows how STAAR's financial strategy supports its growth against ophthalmology industry giants.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses as an alternative to laser vision correction. This is a rapidly growing medical market, requiring investment in clinical research and marketing. This chart shows whether the company is using debt to finance its expansion, which could be risky before its technology becomes an industry standard.
Market segment debt to market segment book capitalization - Medical instruments
STAAR Surgical develops and manufactures implantable lenses for vision correction, serving as an alternative to LASIK. The ophthalmic device market demands innovation and clinical evidence. This chart shows the overall debt burden in the sector. It helps understand how STAAR finances its growth and competes with other vision correction methods.
Debt to book value of all companies in the market
STAAR Surgical, a manufacturer of implantable lenses, operates in the elective healthcare sector, which is dependent on consumer disposable income. This chart shows the overall debt burden of the economy. It helps assess how consumers' overall financial situation influences their willingness to spend money on expensive vision-improving procedures.
P/E of the company, segment and market as a whole
P/E - STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses for vision correction, serving as an alternative to LASIK. This chart shows the market's assessment of the potential of this innovative technology. The high value reflects investors' belief that more patients and surgeons will choose EVO ICL lenses, leading to rapid revenue and profit growth.
P/E of the market segment - Medical instruments
STAAR Surgical operates in the innovative medical devices sector. This chart shows the average price-to-earnings ratio for this fast-growing industry. A company's price-to-earnings ratio (P/E) is significantly higher than average, indicating that investors believe its implantable lenses are a revolutionary product with the potential to disrupt traditional vision correction methods and capture a huge market.
P/E of the market as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to laser surgery. The company's growth depends on the acceptance of its technology by surgeons and patients. This chart shows the overall sentiment in the healthcare sector. It helps understand whether the STAAR score is part of the overall growth of the medical technology market or the result of a unique breakthrough in ophthalmology.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to LASIK. This chart shows market expectations for the growing penetration of this technology in ophthalmology. Future profits depend on successful marketing among physicians and patients, as well as geographic expansion.
%20P%2FE%20STAAR%20Surgical%20Company&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-STAAR-Surgical-Company&v=1772659732031 "Chart of the company's future (projected) P/E STAAR Surgical Company")
Future (projected) P/E of the market segment - Medical instruments
STAAR Surgical produces implantable lenses for vision correction, offering an alternative to LASIK surgery. This chart compares the company's future profitability expectations with those of the medical device industry. It demonstrates how much investors believe in the growth potential of its technology and its ability to capture share of the vast refractive surgery market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772659732038 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to LASIK surgery. The company's success depends on consumer spending on expensive medical procedures. This chart, showing overall market expectations, reflects consumer confidence. Rising optimism encourages people to invest in their health and quality of life.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772659732049 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit STAAR Surgical Company
STAAR Surgical develops and manufactures implantable vision correction lenses as an alternative to LASIK. The company's success is directly dependent on the growing number of surgeons using its technology and consumer demand for ophthalmological procedures. This chart shows how international expansion and technology adoption impact financial performance.
Profit of companies in the market segment - Medical instruments
STAAR Surgical manufactures and sells implantable collamer lenses (ICLs) for vision correction, serving as an alternative to LASIK. The overall profitability of the medical device sector, shown in the graph, is driven by the implementation of innovative technologies. STAAR's success in promoting its less invasive procedure directly impacts the growth and profitability of the entire ophthalmology market.
Overall market profit
STAAR Surgical is changing the world of vision correction with its implantable contact lenses. This is a rapidly growing market driven by technological innovation and demographic trends. The company's success depends less on short-term economic fluctuations and more on the acceptance of its technology by surgeons and patients, demonstrating the power of breakthrough medical products.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to LASIK surgery. Future revenue projections reflected here depend on the global adoption of their technology and the growth of their board-certified surgeons. Analysts estimate the potential to capture market share from traditional vision correction methods.
%20profit%20of%20the%20company%20STAAR%20Surgical%20Company&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-STAAR-Surgical-Company&v=1772659732070 "Graph of future (projected) profit of the company STAAR Surgical Company")
Future (predicted) profit of companies in the market segment - Medical instruments
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to laser surgery. This chart shows overall profitability forecasts for the medical devices sector. It helps understand how the company's innovative product could impact the ophthalmology market and how its prospects relate to overall trends in medical devices.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772659732074 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction. This is a routine medical product, and demand for it depends on consumer disposable income. This trend is important because during periods of economic growth and confidence, people are more willing to spend money on procedures that improve quality of life but are not considered emergency procedures, which drives STAAR sales.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772659732087 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to laser surgery. This multiple, which links market value to sales, reflects investors' faith in its innovative technology. It represents a high premium per dollar of revenue, suggesting expectations that it will displace traditional vision correction methods.
P/S market segment - Medical instruments
STAAR Surgical has made a breakthrough in ophthalmology with its implantable collamer lenses (ICLs), an alternative to laser vision correction. The company is changing the way people correct their vision. This chart shows the premium the market is willing to pay for revenue in the innovative medical device sector, reflecting expectations for the growing penetration of ICL technology worldwide.
P/S of the market as a whole
STAAR Surgical develops, manufactures, and markets implantable lenses for vision correction, offering an alternative to laser surgery. The company's growth is driven by the acceptance of its technology by surgeons and patients. Using this chart, you can compare the innovative medical company's revenue estimates with overall market expectations to understand the premium for its technological leadership.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company STAAR Surgical Company
STAAR Surgical develops, manufactures, and markets implantable lenses for vision correction. This chart illustrates how investors value the company based on its projected future revenue. It reflects the market's confidence in the growing popularity of its products as an alternative to laser vision correction and glasses, as well as its successful expansion into international markets.
%20P%2FS%20STAAR%20Surgical%20Company&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-STAAR-Surgical-Company&v=1772659732106 "The graph of the company's future (projected) P/S STAAR Surgical Company")
Future (projected) P/S of the market segment - Medical instruments
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to laser surgery. This chart shows how the market values the company's future revenue compared to medical equipment manufacturers. A high valuation reflects confidence in the growing popularity of its EVO ICL technology, particularly in Asian markets, while a low valuation reflects competition from traditional methods.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772659732112 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to laser surgery. The company's growth is driven by an aging population and people's desire for a better quality of life. This revenue outlook chart reflects investor confidence in the long-term growth of the medical technology sector and consumer spending on healthcare.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772659732115 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales STAAR Surgical Company
This chart illustrates STAAR Surgical's success in transforming the vision correction industry. The company's revenue depends almost entirely on sales of its implantable contact lenses (ICLs), an alternative to LASIK surgery. Sales growth reflects the growing acceptance of this technology among both doctors and patients worldwide.
Sales of companies in the market segment - Medical instruments
STAAR Surgical develops, manufactures, and markets implantable ocular lenses, offering an alternative to laser vision correction. The company's flagship product is transforming the ophthalmology market. This chart shows the total revenue of the entire medical vision correction device market, demonstrating the growth potential of innovative technologies like STAAR's.
Overall market sales
STAAR Surgical Company develops and manufactures implantable lenses for vision correction, offering an alternative to glasses and LASIK. This premium product, and demand for it, depends on consumer disposable income. This graph, reflecting overall purchasing power, is an indicator of people's willingness to invest in expensive medical procedures that improve quality of life.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to laser surgery. The company's future sales depend on the acceptance of its technology by surgeons and patients worldwide. This chart reflects analysts' expectations for refractive surgery market growth and STAAR's market share.
%20sales%20of%20the%20company%20STAAR%20Surgical%20Company&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-STAAR-Surgical-Company&v=1772659732148 "Schedule of future (projected) sales of the company STAAR Surgical Company")
Future (projected) sales of companies in the market segment - Medical instruments
STAAR Surgical develops, manufactures, and markets implantable ocular lenses. This chart shows sales forecasts segmented by key products, such as the EVO Visian ICL, and by geographic region. This allows analysts to assess which markets and products the company believes will achieve the greatest growth.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772659732156 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Healthcare spending forecasts, which are part of the overall economic expectations in this chart, are important for STAAR Surgical. The company produces implantable lenses for vision correction. Demand for its products depends on patients' willingness to pay for expensive surgeries, which is directly related to rising incomes and confidence.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772659732160 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality STAAR Surgical Company
STAAR Surgical manufactures and markets implantable collamer lenses (ICLs)—an alternative to laser vision correction. This chart shows the profitability of this innovative medical product. Its high profitability is driven by its unique technology, strong patent protection, and growing acceptance by surgeons and patients worldwide seeking a reversible vision correction solution.
Market segment marginality - Medical instruments
STAAR Surgical develops, manufactures, and markets implantable vision correction lenses as an alternative to LASIK. The company's profitability is based on its innovative and patented technology. This chart shows the average profitability in the medical device sector. It helps assess how successfully STAAR Surgical is promoting its technology in the global market.
Market marginality as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction. Demand for these products, often an alternative to laser vision correction, depends on consumer discretionary spending. This chart reflects overall consumer confidence, demonstrating whether people are willing to spend significant amounts to improve their quality of life beyond what insurance covers.
Employees in the company, segment and market as a whole
Number of employees in the company STAAR Surgical Company
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to LASIK. This chart reflects the size of the team dedicated to manufacturing, clinical research, and marketing. The growth in the chart is directly related to the increasing global recognition of their technology and their expanding presence in the Asian and European markets.
Share of the company's employees STAAR Surgical Company within the market segment - Medical instruments
STAAR Surgical has revolutionized vision correction with its EVO ICL implantable lenses, an alternative to LASIK. This business requires high-precision manufacturing and skilled specialists. This chart shows STAAR's share of all workers in the ophthalmic technology niche, reflecting its innovative leadership and growing acceptance of the technology.
Number of employees in the market segment - Medical instruments
STAAR Surgical develops, manufactures, and markets implantable ocular lenses, offering an alternative to laser vision correction. This chart shows employment trends in the medical instrument sector. The growth in the number of specialists in this industry reflects the introduction of new technologies and the increasing demand for minimally invasive procedures, which contributes to the expansion of the market for STAAR's products.
Number of employees in the market as a whole
STAAR Surgical develops and manufactures implantable lenses for vision correction. Their growth depends on demographic trends and the acceptance of their technology by surgeons and patients. This overall employment rate has an indirect impact. A key driver for STAAR is the growing number of people seeking alternatives to glasses and laser vision correction.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company STAAR Surgical Company (STAA)
STAAR Surgical develops and manufactures implantable lenses for vision correction. It's a high-tech medical business. This chart shows how the market values their innovative product and patents. Value is generated both by research and development and by precision manufacturing, which requires skilled specialists.
%20of%20the%20company%20STAAR%20Surgical%20Company%20(STAA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-STAAR-Surgical-Company-STAA&v=1772659732239 "Chart of market capitalization per employee (in thousands of dollars) of the company STAAR Surgical Company (STAA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
STAAR Surgical produces implantable contact lenses (ICLs) for vision correction, an alternative to LASIK. This is a high-tech medical product. Its value lies in its patents, clinical data, and manufacturing know-how. This chart helps assess how the market perceives their unique ophthalmological technology.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772659732246 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
STAAR Surgical develops and manufactures implantable lenses for vision correction, offering an alternative to LASIK. It is an innovative medical product with high growth potential. This graph shows the high market valuation per employee, reflecting the value of the unique technology and intellectual property created by its team of engineers and scientists.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772659732262 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company STAAR Surgical Company (STAA)
STAAR Surgical produces implantable contact lenses (ICLs), offering an alternative to LASIK for vision correction. It's a high-tech medical product with high added value. This chart shows how effectively their team—from R&D to manufacturing and marketing (surgeon training)—translates this innovative technology into profit.
%20Chart%20STAAR%20Surgical%20Company%20(STAA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-STAAR-Surgical-Company-STAA&v=1772659732264 "Company Profit Per Employee (in thousands of dollars) Chart STAAR Surgical Company (STAA)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
STAAR Surgical is a "medtech" company. They produce "implantable contact lenses" (ICLs)—an "alternative" to glasses and LASIK. This graph shows the benchmark for the "medtech" sector. In this "B2B" sector (selling to surgeons), the benchmark is *very* high. Profit per employee is generated by "patents" and a "high markup" on a "consumable" (lens) for "aesthetic" (elective) surgery.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772659732270 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
STAAR Surgical is changing ophthalmology. Instead of LASIK, they offer implantable contact lenses (ICLs) for vision correction. This is a premium medical device. Their business model is based on R&D, high-precision manufacturing, and surgeon training. This chart shows how effective this innovative medical technology company, relying on science and marketing, is in generating revenue per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772659732284 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee STAAR Surgical Company (STAA)
STAAR Surgical produces implantable lenses for vision correction, offering an alternative to LASIK. Revenue per employee at this medical technology company reflects the success of its product promotion among surgeons. The graph shows the growth of lens sales and the effectiveness of its team, which trains doctors and expands its presence in global markets.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-STAAR-Surgical-Company-STAA&v=1772659732292 "Sales chart per company employee STAAR Surgical Company (STAA)")
Sales per employee in the market segment - Medical instruments
STAAR Surgical is changing the vision correction market with its implantable contact lenses (ICLs)—an alternative to LASIK. This medical technology is a breakthrough. This chart reflects the effectiveness of their commercialization. It shows how effectively their team (R&D, marketing, and sales) convinces surgeons and patients to use their premium product over traditional methods.
Sales per employee for the market as a whole
STAAR Surgical (STAA) is transforming the vision correction market with its implantable contact lenses (ICLs), an alternative to LASIK. This high-tech medical product is a breakthrough in the field of vision correction. This chart demonstrates the performance of a business based on this innovative product. Each ICL (such as the EVO Visian) sold generates a high margin. This growth reflects the successful market launch and scaling of production.
Short shares by company, segment and market as a whole
Shares shorted by company STAAR Surgical Company (STAA)
STAAR Surgical is disrupting the vision correction market by offering implantable contact lenses (ICLs) as an alternative to LASIK. Their EVO Visian ICL is implanted into the eye, providing clear vision. This chart shows bearish sentiment. Sellers could bet on the company's growth slowing, or on LASIK procedures remaining dominant, as well as highlighting the risks associated with regulatory approvals in various countries.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-STAAR-Surgical-Company-STAA&v=1772659732340 "Short Shares Chart for the Company STAAR Surgical Company (STAA)")
Shares shorted by market segment - Medical instruments
STAAR Surgical (STAA) produces implantable contact lenses (ICLs) for vision correction, an alternative to LASIK. Their business is aesthetic medicine. This chart measures pessimism for the medical devices sector. If investors are short the industry, they expect consumers to postpone expensive elective procedures like vision correction due to inflation.
Shares shorted by the overall market
STAAR Surgical (STAA) produces implantable lenses (an alternative to LASIK). This is an expensive, optional procedure. This "Short_All" chart reflects consumer pessimism. When it rises, this fear of a recession causes people to postpone expensive elective surgeries, which directly impacts STAA sales.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator STAAR Surgical Company (STAA)
STAAR Surgical is a manufacturer of intraocular contact lenses (ICLs) for vision correction, a direct alternative to LASIK. It's a growth story in ophthalmology. This chart measures investor confidence in this technology. It shows when the stock is overbought on expectations of LASIK being supplanted or oversold on fears of a growth slowdown.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-STAAR-Surgical-Company-STAA&v=1772659732378 "RSI 14 indicator chart for the company's stock STAAR Surgical Company (STAA)")
RSI 14 Market Segment - Medical instruments
STAAR Surgical develops and manufactures implantable collamer lenses (ICLs). They are an alternative to LASIK, especially for patients with high myopia. This metric measures the overall momentum of the ophthalmology equipment sector and helps determine whether the entire segment is being oversold due to declining demand for elective (non-essential) surgeries.
RSI 14 for the overall market
STAAR Surgical (STAA) produces implantable lenses (an alternative to LASIK). This chart is an indicator of expensive elective procedures. During periods of euphoria and the "wealth effect," people are willing to spend thousands on vision "upgrades." During times of panic and recession, these "non-essential" procedures are postponed indefinitely.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast STAA (STAAR Surgical Company)
STAAR Surgical produces implantable collamer lenses (ICLs), an alternative to laser vision correction (LASIK). This chart shows the average target price. Analysts' forecasts are based on the growing number of ICL procedures, particularly in Asian markets, and the company's ability to capture market share from traditional refractive surgery.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-STAA-STAAR-Surgical-Company&v=1772659732541 "A chart showing analyst consensus forecasts for the expected stock price. STAA (STAAR Surgical Company)")
The difference between the consensus estimate and the actual stock price STAA (STAAR Surgical Company)
STAAR Surgical (STAA) is a manufacturer of implantable contact lenses (ICLs), an alternative to laser vision correction (LASIK). This chart shows the valuation of their technology. It measures the gap between the price and the consensus target, reflecting whether analysts believe their lenses (EVO) will continue to gain market share from LASIK, particularly in Asia.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-STAA-STAAR-Surgical-Company&v=1772659732593 "A chart showing the difference between the consensus forecast and the actual stock price. STAA (STAAR Surgical Company)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
STAAR Surgical is a manufacturer of implantable contact lenses (ICLs), an alternative to laser vision correction (LASIK). This chart shows the general expectations of analysts for the medical device sector. It reflects whether experts believe this reversible vision correction procedure will grow in popularity.
Analysts' consensus forecast for the overall market share price
STAAR Surgical (STAA) is a revolution in vision. These are implantable contact lenses (ICLs), an alternative to LASIK (laser correction). It's a 100% elective (optional) procedure. This chart, reflecting expert expectations, is a forecast for them. If the market is pessimistic, consumers postpone expensive ($5,000+) eye surgery.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index STAAR Surgical Company
STAAR Surgical is a disruptor in ophthalmology. Their product, the EVO implantable lens (ICL), is an alternative to laser vision correction (LASIK) for people with myopia. This chart is an indicator of technology adoption. It likely aggregates the growth rate of their lens implant procedures (especially in Asia) and their competition for market share from the older LASIK.
AKIMA Market Segment Index - Medical instruments
STAAR Surgical (STAA) is a vision correction revolution; the company produces an implantable lens (EVO ICL) – an alternative to LASIK that doesn't remove tissue but is inserted into the eye. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this breakthrough technology (ICL) differentiate STAAR from its average medtech competitor?
The AKIM Index for the overall market
STAAR Surgical is a manufacturer of intraocular contact lenses (ICLs) for vision correction. They are a premium alternative to laser vision correction and glasses. This chart, reflecting the market average, provides context. It helps assess how this business, dependent on consumer discretionary medical spending, fares against the backdrop of overall macroeconomic fluctuations.
